Apr 7, 2016

Advances in Magnetic Resonance Imaging Contrast Agents for Biomarker Detection

Annual Review of Analytical Chemistry
Sanhita Sinharay, Mark D Pagel


Recent advances in magnetic resonance imaging (MRI) contrast agents have provided new capabilities for biomarker detection through molecular imaging. MRI contrast agents based on the T2 exchange mechanism have more recently expanded the armamentarium of agents for molecular imaging. Compared with T1 and T2* agents, T2 exchange agents have a slower chemical exchange rate, which improves the ability to design these MRI contrast agents with greater specificity for detecting the intended biomarker. MRI contrast agents that are detected through chemical exchange saturation transfer (CEST) have even slower chemical exchange rates. Another emerging class of MRI contrast agents uses hyperpolarized (13)C to detect the agent with outstanding sensitivity. These hyperpolarized (13)C agents can be used to track metabolism and monitor characteristics of the tissue microenvironment. Together, these various MRI contrast agents provide excellent opportunities to develop molecular imaging for biomarker detection.

  • References91
  • Citations14


  • References91
  • Citations14


Mentioned in this Paper

Biological Markers
Metabolic Process, Cellular
ErbB-2 Receptor
Molecular Imaging
Tumor Cells, Uncertain Whether Benign or Malignant
Biochemical Pathway
Hydrogen Ion Concentration Measurement

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

Annual Review of Biochemistry
Yosef Gruenbaum
Annual Review of Analytical Chemistry
Damien W M Arrigan, Yang Liu
Annual Review of Analytical Chemistry
James H Wade, Ryan C Bailey
© 2020 Meta ULC. All rights reserved